EBR:GBLB

Groupe Bruxelles Lambert Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume157,115 shs
Average Volume162,444 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Groupe Bruxelles Lambert (EBR:GBLB) Vs. DWS, GLJ, MLP, DBAN, ACKB, and BME

Should you be buying GBLB stock or one of its competitors? Companies in the industry of "asset management" are considered alternatives and competitors to Groupe Bruxelles Lambert, including DWS Group GmbH & Co. KGaA (DWS), Grenke (GLJ), MLP (MLP), Deutsche Beteiligungs (DBAN), Ackermans & Van Haaren (ACKB), and BlackRock Health Sciences Trust (BME).

Groupe Bruxelles Lambert (EBR:GBLB) and DWS Group GmbH & Co. KGaA (ETR:DWS) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.

Valuation & Earnings

This table compares Groupe Bruxelles Lambert and DWS Group GmbH & Co. KGaA's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Groupe Bruxelles LambertN/AN/AN/AN/AN/A
DWS Group GmbH & Co. KGaA$3.46 billion2.12$604 million€3.0212.14

DWS Group GmbH & Co. KGaA has higher revenue and earnings than Groupe Bruxelles Lambert.

Analyst Ratings

This is a breakdown of recent recommendations for Groupe Bruxelles Lambert and DWS Group GmbH & Co. KGaA, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Groupe Bruxelles Lambert0000N/A
DWS Group GmbH & Co. KGaA021002.83

DWS Group GmbH & Co. KGaA has a consensus price target of €39.92, suggesting a potential upside of 8.89%.

Profitability

This table compares Groupe Bruxelles Lambert and DWS Group GmbH & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Groupe Bruxelles LambertN/AN/AN/A
DWS Group GmbH & Co. KGaAN/AN/AN/A

Summary

DWS Group GmbH & Co. KGaA beats Groupe Bruxelles Lambert on 2 of the 2 factors compared between the two stocks.

Groupe Bruxelles Lambert (EBR:GBLB) and Grenke (ETR:GLJ) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.

Valuation & Earnings

This table compares Groupe Bruxelles Lambert and Grenke's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Groupe Bruxelles LambertN/AN/AN/AN/AN/A
Grenke$562.70 million2.56$77.65 million€1.6718.56

Grenke has higher revenue and earnings than Groupe Bruxelles Lambert.

Analyst Ratings

This is a breakdown of recent recommendations for Groupe Bruxelles Lambert and Grenke, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Groupe Bruxelles Lambert0000N/A
Grenke12302.33

Grenke has a consensus price target of €65.83, suggesting a potential upside of 112.37%.

Profitability

This table compares Groupe Bruxelles Lambert and Grenke's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Groupe Bruxelles LambertN/AN/AN/A
GrenkeN/AN/AN/A

Summary

Grenke beats Groupe Bruxelles Lambert on 2 of the 2 factors compared between the two stocks.

Groupe Bruxelles Lambert (EBR:GBLB) and MLP (ETR:MLP) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.

Valuation & Earnings

This table compares Groupe Bruxelles Lambert and MLP's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Groupe Bruxelles LambertN/AN/AN/AN/AN/A
MLP$753.01 million1.03$43.07 million€0.4017.93

MLP has higher revenue and earnings than Groupe Bruxelles Lambert.

Analyst Ratings

This is a breakdown of recent recommendations for Groupe Bruxelles Lambert and MLP, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Groupe Bruxelles Lambert0000N/A
MLP01102.50

MLP has a consensus price target of €8.85, suggesting a potential upside of 24.65%.

Profitability

This table compares Groupe Bruxelles Lambert and MLP's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Groupe Bruxelles LambertN/AN/AN/A
MLPN/AN/AN/A

Summary

MLP beats Groupe Bruxelles Lambert on 2 of the 2 factors compared between the two stocks.

Groupe Bruxelles Lambert (EBR:GBLB) and Deutsche Beteiligungs (ETR:DBAN) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.

Valuation & Earnings

This table compares Groupe Bruxelles Lambert and Deutsche Beteiligungs' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Groupe Bruxelles LambertN/AN/AN/AN/AN/A
Deutsche Beteiligungs$39.80 million16.02$11.09 million€0.5957.46

Deutsche Beteiligungs has higher revenue and earnings than Groupe Bruxelles Lambert.

Analyst Ratings

This is a breakdown of recent recommendations for Groupe Bruxelles Lambert and Deutsche Beteiligungs, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Groupe Bruxelles Lambert0000N/A
Deutsche Beteiligungs00503.00

Deutsche Beteiligungs has a consensus price target of €45.44, suggesting a potential upside of 34.04%.

Profitability

This table compares Groupe Bruxelles Lambert and Deutsche Beteiligungs' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Groupe Bruxelles LambertN/AN/AN/A
Deutsche BeteiligungsN/AN/AN/A

Summary

Deutsche Beteiligungs beats Groupe Bruxelles Lambert on 2 of the 2 factors compared between the two stocks.

Groupe Bruxelles Lambert (EBR:GBLB) and Ackermans & Van Haaren (EBR:ACKB) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.

Valuation & Earnings

This table compares Groupe Bruxelles Lambert and Ackermans & Van Haaren's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Groupe Bruxelles LambertN/AN/AN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations for Groupe Bruxelles Lambert and Ackermans & Van Haaren, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Groupe Bruxelles Lambert0000N/A
Ackermans & Van Haaren0000N/A

Profitability

This table compares Groupe Bruxelles Lambert and Ackermans & Van Haaren's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Groupe Bruxelles LambertN/AN/AN/A
Ackermans & Van HaarenN/AN/AN/A

Groupe Bruxelles Lambert (EBR:GBLB) and BlackRock Health Sciences Trust (BME:BME) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.

Valuation & Earnings

This table compares Groupe Bruxelles Lambert and BlackRock Health Sciences Trust's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Groupe Bruxelles LambertN/AN/AN/AN/AN/A
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations for Groupe Bruxelles Lambert and BlackRock Health Sciences Trust, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Groupe Bruxelles Lambert0000N/A
BlackRock Health Sciences Trust0000N/A

Profitability

This table compares Groupe Bruxelles Lambert and BlackRock Health Sciences Trust's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Groupe Bruxelles LambertN/AN/AN/A
BlackRock Health Sciences TrustN/AN/AN/A


Groupe Bruxelles Lambert Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
DWS Group GmbH & Co. KGaA logo
DWS
DWS Group GmbH & Co. KGaA
1.9$36.66flat$7.33 billion$3.46 billion12.14Analyst Report
High Trading Volume
Grenke logo
GLJ
Grenke
1.8$31.00flat$1.44 billion$562.70 million18.56High Trading Volume
MLP logo
MLP
MLP
1.5$7.10flat$772.20 million$753.01 million17.93Upcoming Earnings
Deutsche Beteiligungs logo
DBAN
Deutsche Beteiligungs
1.7$33.90flat$637.49 million$39.80 million57.46Upcoming Earnings
ACKB
Ackermans & Van Haaren
0.5N/AN/A$0.00N/A0.00Gap Up
BlackRock Health Sciences Trust logo
BME
BlackRock Health Sciences Trust
0.5N/AN/A$0.00N/A0.00
BlackRock Income Trust logo
BKT
BlackRock Income Trust
0.4N/AN/A$0.00N/A0.00
BNY Mellon Strategic Municipal Bond Fund logo
DSM
BNY Mellon Strategic Municipal Bond Fund
0.6N/AN/A$0.00N/A0.00
Rand Capital logo
RAND
Rand Capital
0.4N/AN/A$0.00N/A0.00
PYX
Schroders
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.